中华皮肤科杂志 ›› 2016, Vol. 49 ›› Issue (1): 36-39.

• 论著 • 上一篇    下一篇

长脉冲1064 nm Nd:YAG激光治疗婴儿血管瘤5年回顾分析

钟淑霞1,周俊峰1,姚蕾1,宋洋2,刘媛媛1,闫冬雪1,李珊山3   

  1. 1. 吉林大学第一医院
    2. 吉林大学第一医院皮肤性病科
    3. 长春市吉林大学第一医院皮肤科
  • 收稿日期:2015-03-23 修回日期:2015-09-27 出版日期:2016-01-15 发布日期:2015-12-31
  • 通讯作者: 李珊山 E-mail:shansalee@163.com

Long-pulsed 1064-nm Nd:YAG laser in the treatment of infantile hemangioma: a 5-year retrospective analysis

  • Received:2015-03-23 Revised:2015-09-27 Online:2016-01-15 Published:2015-12-31

摘要:

目的 评价长脉冲1064 nm Nd:YAG激光治疗婴儿血管瘤的临床效果和特点。 方法 吉林大学第一医院皮肤科门诊接受1064 nm Nd:YAG激光治疗的资料完整的婴儿血管瘤病例共794例(900处血管瘤),回顾性分析患者临床资料,包括患者年龄、性别,血管瘤发生时间、病程、类型、位置、面积、并发症及治疗结果。不同性别间的疗效比较采用两组秩和检验;不同疗效患儿的年龄和血管瘤的面积采用中位数 ± 四分位数间距进行描述,组间比较采用多组秩和检验;不同血管瘤的位置和不同血管瘤分类间的疗效比较均采用多组秩和检验;影响血管瘤疗效的多因素分析方法采用有序多分类logistic回归法。 结果 794例患儿经1 ~ 5次激光治疗后,总有效率为87.56%(788/900)。疗效与患儿的性别(Z = -7.18,P > 0.05)和血管瘤的位置(χ2 =2.34,P > 0.05)无关,而主要与患儿的年龄(χ2 = 103.131,P < 0.001)和血管瘤类型(χ2 = 107.709,P < 0.001)相关。年龄越大,疗效越好(OR = 1.21,95% CI 1.14 ~ 1.28,P < 0.001);同单纯血管瘤比较,混合型血管瘤疗效最差(OR = 0.22,95% CI 0.17 ~ 0.29,P < 0.001),其次为深层血管瘤(OR = 0.30,95% CI 0.10 ~ 0.93,P = 0.037)。不良反应包括术后水疱、萎缩性瘢痕、色素沉着、色素减退、皮肤质地改变,未见增生性瘢痕。 结论 1064 nm Nd:YAG激光是治疗各种类型早期婴儿血管瘤的有效手段之一。

Abstract:

Zhong Shuxia, Zhou Junfeng, Tao Yuchun, Yao Lei, Song Yang, Liu Yuanyuan, Yan Dongxue, Li Shanshan Department of Dermatology, First Hospital of Jilin University, Changchun 130021, China (Zhong SX, Zhou JF, Yao L, Song Y, Liu YY, Yan DX, Li SS); Department of Epidemiology and Health Statistics, School of Public Health, Jilin University, Changchun 130012, China (Tao YC) Corresponding author: Li Shanshan, Email: shansalee@163.com 【Abstract】 Objective To evaluate the clinical efficacy and characteristics of long-pulsed 1064-nm Nd:YAG laser in the treatment of infantile hemangioma. Methods Totally, 794 cases of infantile hemangioma (including 900 hemangioma lesions) treated with long-pulsed 1064-nm Nd:YAG laser in the First Hospital of Jilin University were included into this study. Clinical data were collected from these patients, including age, gender, age at onset of hemangioma, disease course, clinical types, lesional location and area, complications and treatment outcome. A retrospective analysis was carried out. The Mann-Whitney test was performed to compare therapeutic effects between male and female patients, and the Kruskal-Wallis H test to compare those among hemangioma at different sites and of different types. The central tendency and variability in patients′ age and lesional area were expressed as median ± quartile range, and compared by the Kruskal-Wallis H test among hemangioma showing different therapeutic response. Factors influencing therapeutic response were analyzed by an ordinal multinomial logistic regression analysis. Results After 1 - 5 sessions of laser therapy, the total response rate was 87.56% (788/900) in the 794 patients with infantile hemangioma. There were significant differences in therapeutic response among patients of different ages (χ2 = 103.131, P < 0.001), among different types of hemangioma (χ2 = 107.709, P < 0.001), and among different areas of hemangioma (χ2 = 59.35, P < 0.001), but not between male and female patients (Z = -7.18, P > 0.05) or among hemangioma at different sites (χ2 = 2.34, P > 0.05). As the ordinal multinomial logistic regression analysis showed, the older the age, the better the therapeutic response (OR = 1.21, 95% CI: 1.14 - 1.28, P < 0.001). In addition, the therapeutic response was worse in subcutaneous hemangioma than in superficial hemangioma (OR = 0.30, 95% CI: 0.10 - 0.93, P = 0.037), and worst in mixed hemangioma (OR = 0.22, 95% CI: 0.17 - 0.29, P < 0.001). Adverse reactions included blisters, atrophic scars, hyperpigmentation, hypopigmentation and changes in skin texture, but no hyperplastic scars were observed. Conclusion Long-pulsed 1064-nm Nd:YAG laser is highly effective for the treatment of various kinds of infantile hemangioma in early stage with a good safety profile.